News

Published on 28 Sep 2022 on Zacks via Yahoo Finance

Has IMARA (IMRA) Outpaced Other Medical Stocks This Year?


Article preview image

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has IMARA Inc. (IMRA) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.

IMARA Inc. is one of 1184 companies in the Medical group. The Medical group currently sits at #6 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. IMARA Inc. is currently sporting a Zacks Rank of #2 (Buy).

NASDAQ.VIRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Viracta Therapeutics Inc (VIRX) Reports Q3 2023 Financial Results Amid Clinical Advances

Viracta Therapeutics Inc (NASDAQ:VIRX) announced preliminary clinical data from the NAVAL-1 trial...

GuruFocus.com via Yahoo Finance 9 Nov 2023

WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months

WAVE Life Sciences Ltd. (NASDAQ:WVE), a preclinical biopharmaceutical company, has seen a signifi...

GuruFocus.com via Yahoo Finance 23 Aug 2023

Viracta Therapeutics Says Pivotal Cancer Trial Achieves Efficacy Threshold For Expansion Into Next...

Viracta Therapeutics IncĀ (NASDAQ: VIRX) announced that the relapsed or refractory EBV+ peripheral...

Benzinga via Yahoo Finance 28 Jun 2023

Has IMARA (IMRA) Outpaced Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 28 Sep 2022

Viracta (VIRX) Up on Orphan Drug Tag for Peripheral Lymphoma

Viracta Therapeutics VIRX increased 11.9% during market hours on Sep 7. The upside followed after...

Zacks via Yahoo Finance 8 Sep 2022

4 Small Stocks to Bet on in an Upbeat Drugs Industry

The drug/biotech sector has been witnessing developments in pipeline areas like rare diseases, ge...

Zacks via Yahoo Finance 27 Jun 2022

Here's Why Assertio Holdings (ASRT) Stock is Up This Year

Assertio Holdings ASRT stock has risen 45.9% this year so far against a 20.3% decrease for the in...

Zacks via Yahoo Finance 27 Jun 2022

Here's Why Viracta Therapeutics (VIRX) is Up So Far This Year

Viracta Therapeutics VIRX stock has risen 24.1% this year so far against an 18.5% decrease for th...

Zacks via Yahoo Finance 27 Jun 2022

What Type Of Shareholders Own The Most Number of Viracta Therapeutics, Inc. (NASDAQ:VIRX) Shares?

A look at the shareholders of Viracta Therapeutics, Inc. (NASDAQ:VIRX) can tell us which group is...

Simply Wall St. via Yahoo Finance 24 May 2022

What Kind Of Shareholders Hold The Majority In Viracta Therapeutics, Inc.'s (NASDAQ:VIRX) Shares?

The big shareholder groups in Viracta Therapeutics, Inc. (NASDAQ:VIRX) have power over the compan...

Simply Wall St. via Yahoo Finance 22 Feb 2022